Navigation Links
ParagonRx Creates New Website Featuring REMS Help Center for Pharma
Date:7/13/2009

WILMINGTON, Del., July 13 /PRNewswire/ -- ParagonRx, a Delaware-based company which specializes in programs for the appropriate use of medications, has launched a new website - www.paragonrx.com - that includes a "REMS Hub" for pharmaceutical and biotech companies needing information and assistance in complying with new FDA requirements to ensure the medical benefits of a drug outweigh its risks and dangerous side effects.

"REMS, or Risk Evaluation and Mitigation Strategy, requires a whole new mindset for many professionals in the industry," according to ParagonRx CEO Jeffrey Fetterman, "in that patient safety is no longer merely a statistic that is passively measured for regulatory compliance. Now, patient safety is an objective that is actively managed by many functional groups and disciplines, including pharmacovigilance, marketing, medical, regulatory and legal. In many ways, risk management, including REMS, is becoming its own new discipline, and we believe that our online REMS Hub will be of great use to our colleagues in many disciplines.

"Our job is always to make our clients jobs easier," Fetterman continues. "The new website was specifically designed to make it simpler to share the new lessons being learned as we work through the evolving REMS processes. We all share an overwhelming desire to improve patient safety while ensuring the benefits of a pharmaceutical or biological solution can address a patient's health needs. Our goal is to use the website and Internet world to help build better communication and educational strategies reducing risks for physicians and patients."

The REMS Hub addresses the related but varying needs of pharma and bio companies working with risk management and REMS in any of a product's key stages - development, peri-approval, launch, and post-marketing. The Center also explains how a science-based approach to REMS development can assure both safer product use and often broader product use, as well.

(Note to media: Fetterman is available for interviews)


'/>"/>
SOURCE ParagonRx
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Digital Unions RT1(TM) Software Creates Telegenetics Network for Region 3 Genetics Collaborative
2. Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S.
3. MIT creates gecko-inspired bandage
4. ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer
5. CryoPort Creates Personal Wall on Wallst.nets Financial Social Community, my.wallst.net
6. Inclinix Expansion Creates New Position and Promotions
7. Monsantos Industry-Leading Seed Position Creates Accelerated Biotech Trait Opportunity in Latin America
8. New process creates 3-D nanostructures with magnetic materials
9. MRI Expands Energy Role: Launches Center for Integrated Algal Research and Creates Director of Energy Programs Position
10. Pathway for Biosimilars Act Protects Patients, Promotes Competition, Preserves Innovation and Creates Quality Jobs, Lilly Says
11. GSK and Pfizer Innovative Agreement Creates Specialist HIV Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)...  Biotheranostics today announced that new data will ... Cancer Index (BCI) in identifying which patients with ... for disease recurrence and might benefit from extended ... advancing the understanding of the value of BCI ... inform decisions related to patient treatment. These data ...
(Date:12/8/2016)... Portland, Oregon (PRWEB) , ... December 08, 2016 ... ... modules and the FrontPanel SDK that provide essential device-to-computer interconnect using USB or ... do not require FrontPanel support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module ...
(Date:12/8/2016)... ... 08, 2016 , ... KBioBox llc announced today the launch ... developed a sophisticated “3 click” gene dditing off target analysis program and a ... https://www.kbiobox.com/ and powered by the company’s proprietary BioEngine. Scientists, pharmaceutical ...
(Date:12/8/2016)... N.J. , Dec. 8, 2016  Soligenix, ... late-stage biopharmaceutical company focused on developing and commercializing ... an unmet medical need, announced today the long-term ... with SGX942 (dusquetide), a first-in-class Innate Defense Regulator ... in head and neck cancer patients undergoing chemoradiation ...
Breaking Biology Technology:
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, ... solutions for public safety, investigation, corrections and monitoring, announced ... smaller competitor, ICSolutions, to have an independent technology judge ... the most modern high tech/sophisticated telephone calling platform, and ... customers that they do most of what we do ...
(Date:11/15/2016)... , Nov 15, 2016 Research and Markets ... Forecast to 2021" report to their offering. ... ... 16.18 Billion by 2021 from USD 6.21 Billion in 2016, growing ... Growth of the bioinformatics market is driven by the growing ...
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
Breaking Biology News(10 mins):